CAS: 78111-17-8; (R)-2-Hydroxy-3-((2S,5R,6R,8S)-5-Hydroxy-8-((R,E)-4-((2R,4A'R,5R,6'S,8'R,8A'S)-8'-Hydroxy-6'-((1S,3S)-1-Hydroxy-3-((2S,3R,6S)-3-Methyl-1,7-Dioxaspiro[5.5]Undecan-2-yl)Butyl)-7'-Methyleneoctahydro-3H,3'H-Spiro[furan-2,2'-Pyrano[3,2-B]Pyran]-5-yl)But-3-En-2-yl)-10-Methyl-1,7-Dioxaspiro[5.5]Undec-10-En-2-yl)-2-Methylpropanoic Acid

该化合物是一个复杂的有机化合物,其特点是分子结构复杂,包括多种功能组,如二氧化锡,氢氧基和丙酸酸脂.该化合物的立体化学描述仪显示,它具有性能,表明它能够以多种同义形式存在.其结构复杂性可能具有独特的化学特性,有可能影响它与生物系统的反作用和相互作用.多环和立体中心的存在表明它可能具有药物应用或作为有机化学合成中间体.此外,该化合物化学文摘社编号78111-17-8,便于识别和参考化学数据库.总的来说,该物质是化学化合物中现代有机合成和结构多样性的引人入胜的例子.

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号104307-13-3 tribenzyl okada... | CAS号194038-95-4 (((2R,3S)-1-((4... | CAS号194039-05-9 (S)-2-((2S,6R,8...

合成工艺路线路线简述

  • 合成目标产物 Okadaic Acid 主要起始原料 1,7-Dioxaspiro[5.5]Undec-10-Ene-2-Propanoic Acid, α-Hydroxy-α,10-Dimethyl-8-[1-Methyl-3-[octahydro-6′-[3-(3-Methyl-1,7-Dioxaspiro[5.5]Undec-2-yl)-1-(Phenylmethoxy)Butyl]-7-Methylene-8-(Phenylmethoxy)Spiro[furan-2(3H),2′(3′h)-Pyrano[3,2-B]Pyran]-5-Yl]-2-Propenyl]-5-(Phenylmethoxy)-, [2′r-[2′α[r*[1R*[2S*(R*),5R*,6R*,11S*],3E]],4′aβ,6′β[1S*,3S*(2R*,3R*,6S*)],8′α,8′aα]]-
  • (文献来源)合成步骤主要原料 1,7-Dioxaspiro[5.5]Undec-10-Ene-2-Propanoic Acid, α-Hydroxy-α,10-Dimethyl-8-[1-Methyl-3-[octahydro-6′-[3-(3-Methyl-1,7-Dioxaspiro[5.5]Undec-2-yl)-1-(Phenylmethoxy)Butyl]-7-Methylene-8-(Phenylmethoxy)Spiro[furan-2(3H),2′(3′h)-Pyrano[3,2-B]Pyran]-5-Yl]-2-Propenyl]-5-(Phenylmethoxy)-, [2′r-[2′α[r*[1R*[2S*(R*),5R*,6R*,11S*],3E]],4′aβ,6′β[1S*,3S*(2R*,3R*,6S*)],8′α,8′aα]]-
📜3-((2R,4Ar,6S,8R,8Ar)-8-(Benzyloxy)-6-((1S,3S)-1-(Benzyloxy)-3-((2S,3R,6S)-3-Methyl-1,7-Dioxaspiro[5.5]Undecan-2-yl)Butyl)-2-Methoxy-7-Methyleneoctahydropyrano[3,2-B]Pyran-2-yl)Propan-1-Ol置于lithium Hydroxide,Lidbb,Bh3 System,水,戴斯-马丁氧化剂,对甲苯磺酸,N,N-二异丙基乙胺,Lithium Chloride,(S)-2-甲基-Cbs-恶唑硼烷体系中,用 四氢呋喃,乙腈 作为反应溶剂,化学反应生成 黑海棉酸钠盐
参考文献:An Efficient Total Synthesis Of Okadaic Acid
标题:An Efficient Total Synthesis Of Okadaic Acid
摘要:
DOI:10.1021/ja9715206

海关参考信息

专利信息


专利号:WO-2025062384-A2
优先权日:2023-09-23
标题 :A method for synthesis of metal halide perovskite (cspbbr3) nano/microcrystals
发明人:M A GOKUL; RAHMAN ATIKUR
权利人:INDIAN INSTITUTE OF SCIENCE EDUCATION AND RES PUNE IISER PUNE
摘要:The present invention relates to metal halide perovskite (CsPbBr3) nano/microcrystals. Specifically, the present invention relates to a method for the synthesis of metal halide perovskite (CsPbBr3) nano/microcrystals. The present invention uses an easy, scalable low temperature growth of metal halide nanoparticles like CsPbBr3. The method uses a clever play on the solubility and ion exchange mechanism to precipitate nano and microcrystals of metal halide perovskites. The synthesis resulted in stable perovskite crystals with high photo- luminescence, ultralow dark current and control over their morphology. The combination of ultralow dark current, high responsivity, exceptional detectivity, and broad-band photon detection capabilities makes these crystals an excellent choice for upcoming sensors and detector technologies.

专利号:WO-2024137710-A3
优先权日:2022-12-19
标 题 :Improved enzymes and methods for the synthesis of cannabinoids
发明人:KAMBOURAKIS SPIROS; KOMOR RUSSELL SCOTT; CAIAZZA NICKY CHRISTOPHER; KEUL NICHOLAS DONALD; WALKER CALEB MARSHALL
权利人:CELLIBRE INC
摘要:Disclosed herein are novel CBGA and CBGVA synthases and methods for improvement of their overall activities for the synthesis of CBGA and CBGVA from their respective precursors, olivetolic acid (OA) or divarinic acid (DVA) and GPP. Also disclosed are fusion proteins to enhance synthesis of CBGA and CBGVA. The methods described herein also increase the titer and the purity of CBGA and CBGVA made by a cell by 1) decreasing the formation of byproducts FCBGA and FCBGVA that are synthesized from the respective prenylation of OA and DVA with FPP, 2) increasing the intracellular availability of OA and DVA and 3) increasing the speed of CBGA and CBGVA formation, while reducing accumulation of intermediates.

专利号:US-12391691-B2
优先权日:2018-11-16
标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
权利人:AMGEN INC
摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as

专利号:US-2025206736-A1
优先权日:2019-11-14
标题 :Synthesis of kras g12c inhibitor compound
发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
权利人:AMGEN INC
摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

专利号:US-2025171686-A1
优先权日:2023-11-27
标题 :Room temperature ambient synthesis of metal-doped halide perovskite nanocrystals
发明人:FELDMANN SASCHA; WUTTIG MATEO CARDENES; VANORMAN ZACHARY
权利人:ECOLE POLYTECHNIQUE FED LAUSANNE EPFL; PRESIDENT AND FELLOWS OF HARVARD COLLEGE CAMBRIDGE MA
摘要:A method of preparing a composition including crystalline particles of a halide perovskite, a composition and a perovskite-based device including the same. The halide perovskite has a chemical formula ABX3, wherein A is a monocation, B is selected from a combination of lead (II) and a dopant and X is selected from a halide.

专利号:US-2025206743-A1
优先权日:2022-03-25
标 题:Tyk2 inhibitor synthesis and intermediates thereof
发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG
权利人:TAKEDA PHARMACEUTICALS CO
摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J Cancer Res Clin Oncol. 2017 Sep 23. doi: 10.1007/s00432-017-2515-2. [Epub ahead of print] Review. Review. Japanese. pii: E272. doi: 10.3390/toxins8100272. Review.
4: Wakimoto T, Egami Y, Abe I. Calyculin: Nature's way of making the sponge-derived cytotoxin. Nat Prod Rep. 2016 Jun 2;33(6):751-60. doi: 10.1039/c5np00123d. Review. doi: 10.1021/acs.jnatprod.5b01066. Epub 2016 Feb 22. Review. doi: 10.3390/md13106505. Review.
7: Zimmer ER, Leuzy A, Souza DO, Portela LV. Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System. Mol Neurobiol. 2016 Aug;53(6):3753-3755. doi: 10.1007/s12035-015-9321-0. Epub 2015 Jul 4. Review. doi: 10.1186/s12974-015-0291-y. Review.

合成参考文献


摘要:Journal of the American Chemical Society., 103(2469), 1981
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知